Randomized Trial Data on Xuefu Zhuyu Oral Liquid for Stable Angina

A supplementary document from a randomized controlled trial evaluating Xuefu Zhuyu oral liquid as adjunctive therapy for stable angina. The trial involved 148 patients across six hospitals in China between June 2020 and June 2022. The file contains results on pain intensity and rescue medication use, authored by Wencong Cao.

Use Cases

• Analyze adjunctive therapy efficacy based on visual analog scale pain scores mentioned in the description
• Compare rescue medication usage rates between treatment and placebo groups based on nitroglycerin data
• Evaluate safety profiles of traditional Chinese medicine interventions based on adverse event reporting

Strengths

• Data originates from a multicenter, randomized, double-blind, placebo-controlled trial, a rigorous study design
• Results include specific statistical outcomes, such as an adjusted mean difference of -0.63 for pain scores
• The trial followed patients for 24 weeks, providing both short-term and sustained effect data

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• The dataset is a 135.6 KB DOCX file, indicating limited scope and likely summary-level data rather than raw patient records

Provenance

Source

figshare

Collection Method

Data collected as part of a clinical trial conducted across six hospitals.

Time Range

June 2020 to June 2022

Freshness

Last updated 2026-04-29 05:54:23; freshness should be verified

Geography

China